TARA Protara Therapeutics Inc
Company Analysis
Latest News
🔴 Protara Therapeutics is trading 5% down today
Protara Therapeutics is trading 5.23% lower at $2.62 on October 13, 2026; no clear company-specific announcement explaining the decline has surfaced. - A...
🟢 Protara Therapeutics is trading 11.2% up in after-hours trading with no clear catalyst identified
Protara Therapeutics is trading 11.2% up at $3.07 in after-hours trading after closing at $2.76 on October 1, 2026; no clear catalyst has been identified. -...
🔴 Protara Therapeutics is trading 6.9% down
Protara Therapeutics is trading 6.9% lower at $2.84, with no clear company-specific catalyst identified for October 1. - The latest company release located...
🟢 Protara Therapeutics is trading 10% up in pre-market with no clear catalyst
Protara Therapeutics is trading at $3.35, up 9.84%, in pre-market, with no clear company-specific catalyst identified. - The latest company announcement found...
🔴 Protara Therapeutics is trading 5% down; reason unclear
Protara Therapeutics is trading 5.45% down at $3.04, with no clear catalyst identified for the September 30, 2026 decline. - No company-specific announcement...
🟢 Protara Therapeutics is trading 6% up in pre-market
Protara Therapeutics is trading at $3.44, up +5.85%, with no clear reason identified for the September 29, 2026 pre-market gain. - No company-specific...
🔴 Protara Therapeutics is trading 5.5% down today amid risk-off pressure across biotech
Protara Therapeutics is trading at $3.35, down 5.5%, with the decline appearing tied to broader biotech and risk-off pressure. - No new company-specific...
🔴 Protara Therapeutics is trading 5% down today amid rising oil prices and Treasury yields
Protara Therapeutics is trading at $3.50, down 5.03%, as weaker major U.S. indexes, rising oil prices and Treasury yields pressure risk appetite and equity...
🟢 Protara Therapeutics is trading 10.25% up today with no clear catalyst identified
Protara Therapeutics is trading 10.25% up at $3.87 after rising from the September 21 close of $3.51. - No clear company-specific catalyst has been identified...
🟢 Protara Therapeutics is trading 7% up today
Protara Therapeutics is trading 6.98% up at $3.75 after rising from the September 21 close of $3.51; no clear company-specific catalyst has been identified. -...
🟢 Protara Therapeutics is trading 6% up in pre-market with no clear catalyst identified
Protara Therapeutics is trading 6% up now at $4.09 in pre-market, with no clear company-specific catalyst identified for September 1, 2026. - The latest...
🔴 Protara Therapeutics is trading 10.26% down in pre-market
Protara Therapeutics is trading at $3.50 (-10.26%), with no credible company-specific catalyst identified. - No credible August 21, 2026 company-specific...
🔴 Protara Therapeutics is trading 9.1% down today in pre-market with no clear catalyst identified
Protara Therapeutics is trading 9.1% down in pre-market at $3.60, with no credible company-specific announcement dated August 20, 2026, identified. - The...
🔴 Protara Therapeutics is trading 9.1% down today in pre-market with no clear company-specific catalyst
Protara Therapeutics is trading 9.1% down at $3.60 after closing at $3.96 on August 19, 2026; no credible company-specific announcement dated August 20 was...
🔴 Protara Therapeutics is trading 5.23% down today after Q2 loss exceeded expectations
Protara Therapeutics is trading 5.23% down now at $3.90 after reporting second-quarter results that missed analyst expectations. • Q2 loss was $21.7 million,...
Protara Therapeutics reports second quarter 2026 results and expects key clinical enrollment by year-end
Protara Therapeutics reported a second quarter 2026 net loss of $21.7 million, or $0.36 per share, as the company ramped up clinical activity for its lead...
Protara Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 10, 2026
Analysts expect Protara Therapeutics to report a Q2 2026 net loss of $0.33 per share on zero revenue, while the stock currently trades at $4.06, well below the...
🔴 Protara Therapeutics is trading 12.7% down today on no apparent news
Protara Therapeutics is trading 12.7% down at $3.50 in pre-market sessions despite a lack of fresh company-specific catalysts. • The sharp decline marks a...
🟢 Protara Therapeutics is trading 17.4% up today on light liquidity and speculative interest
Protara Therapeutics is trading 17.4% up at $4.60 in pre-market, jumping from its July 31 close of $3.92 on light liquidity and speculative interest. • There...
🟢 Protara Therapeutics is trading 9.7% up today with no clear news catalyst
Protara Therapeutics is trading at $4.30 (9.7%) up today in pre-market as the move appears driven by light liquidity rather than a clear news catalyst. • The...